SE451071B - Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa - Google Patents

Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa

Info

Publication number
SE451071B
SE451071B SE7908995A SE7908995A SE451071B SE 451071 B SE451071 B SE 451071B SE 7908995 A SE7908995 A SE 7908995A SE 7908995 A SE7908995 A SE 7908995A SE 451071 B SE451071 B SE 451071B
Authority
SE
Sweden
Prior art keywords
group
formula
compound
symbols
prepared
Prior art date
Application number
SE7908995A
Other languages
English (en)
Swedish (sv)
Other versions
SE7908995L (sv
Inventor
D Cox
H Cairns
N Chadwick
J L Suschitzky
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE7908995L publication Critical patent/SE7908995L/xx
Publication of SE451071B publication Critical patent/SE451071B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7908995A 1978-10-31 1979-10-30 Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa SE451071B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (2)

Publication Number Publication Date
SE7908995L SE7908995L (sv) 1980-05-01
SE451071B true SE451071B (sv) 1987-08-31

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7908995A SE451071B (sv) 1978-10-31 1979-10-30 Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa

Country Status (32)

Country Link
US (1) US4419352A (fr)
AR (1) AR230449A1 (fr)
AT (1) AT379811B (fr)
AU (1) AU528648B2 (fr)
BR (1) BR7907006A (fr)
CA (1) CA1142520A (fr)
CH (1) CH643264A5 (fr)
CS (1) CS231166B2 (fr)
CU (1) CU21123A (fr)
DD (1) DD146954A5 (fr)
DE (1) DE2943658A1 (fr)
DK (1) DK458679A (fr)
FI (1) FI67702C (fr)
FR (1) FR2440371A1 (fr)
GR (1) GR73861B (fr)
HK (1) HK66185A (fr)
HU (1) HU183087B (fr)
IE (1) IE49464B1 (fr)
IL (1) IL58579A (fr)
KE (1) KE3540A (fr)
LU (1) LU81841A1 (fr)
MA (1) MA18631A1 (fr)
MY (1) MY8500439A (fr)
NL (1) NL7907916A (fr)
NO (1) NO154522C (fr)
NZ (1) NZ191956A (fr)
PH (1) PH15442A (fr)
PL (1) PL130691B1 (fr)
PT (1) PT70392A (fr)
SE (1) SE451071B (fr)
SG (1) SG40885G (fr)
SU (1) SU1014476A3 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
EP0162556B1 (fr) * 1984-04-13 1991-11-06 FISONS plc Formes et formulations des sels de sodium de nédocromil
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
ES2058129T3 (es) * 1986-12-23 1994-11-01 Fisons Plc Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
ATE161837T1 (de) * 1990-07-25 1998-01-15 Teijin Ltd Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
EP1284972A1 (fr) * 2000-05-17 2003-02-26 Cor Therapeutics, Inc. Procedes de production de chromanes amino substitues et intermediaires associes
US9132116B2 (en) 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (fr) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Stabilisateurs de mastocytes utilisés pour prévenir ou traiter la fourbure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
CA1087188A (fr) * 1977-03-08 1980-10-07 Hirosada Sugihara Acides 1-azaxanthone-3-carboxyliques
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
MA18631A1 (fr) 1980-07-01
AU5228779A (en) 1980-05-08
DD146954A5 (de) 1981-03-11
IE49464B1 (en) 1985-10-16
US4419352A (en) 1983-12-06
IL58579A0 (en) 1980-01-31
LU81841A1 (fr) 1980-05-07
NO793469L (no) 1980-05-02
FI793369A (fi) 1980-05-01
FI67702C (fi) 1985-05-10
IL58579A (en) 1985-12-31
HU183087B (en) 1984-04-28
MY8500439A (en) 1985-12-31
CU21123A (es) 1982-08-28
PL219304A1 (fr) 1980-12-01
FR2440371B1 (fr) 1983-01-28
DE2943658C2 (fr) 1991-08-01
KE3540A (en) 1985-07-12
FR2440371A1 (fr) 1980-05-30
SU1014476A3 (ru) 1983-04-23
PL130691B1 (en) 1984-08-31
AT379811B (de) 1986-03-10
SG40885G (en) 1986-05-02
BR7907006A (pt) 1980-07-15
CA1142520A (fr) 1983-03-08
ATA701479A (de) 1985-07-15
CS231166B2 (en) 1984-10-15
CS735979A2 (en) 1984-02-13
DK458679A (da) 1980-05-01
HK66185A (en) 1985-09-13
NO154522B (no) 1986-06-30
DE2943658A1 (de) 1980-05-14
AR230449A1 (es) 1984-04-30
GR73861B (fr) 1984-05-08
PT70392A (en) 1979-11-01
PH15442A (en) 1983-01-18
CH643264A5 (fr) 1984-05-30
FI67702B (fi) 1985-01-31
NO154522C (no) 1986-10-08
NL7907916A (nl) 1980-05-02
AU528648B2 (en) 1983-05-05
IE792074L (en) 1980-04-30
SE7908995L (sv) 1980-05-01
NZ191956A (en) 1984-05-31

Similar Documents

Publication Publication Date Title
SE451071B (sv) Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa
EP0149242B1 (fr) 1-(2-Hydroxyaryl)-alcan-1-one oxime, préparation et utilisation en pharmacie
CH625522A5 (fr)
US3987185A (en) Method of treatment using 1-oxo-1h-2-benzopyran-3-carboxylic acid derivatives
BRPI0916475A2 (pt) imidazo[1,2-a]piridina substituída, de fórmula i ou um sal farmaceuticamente aceitável da mesma, processo para a preparação da imidazo[1,2-a]piridina substituída, composição farmacêutica, e, uso da imidazo[1,2-a]piridina substituída
JPH07503248A (ja) 複素三環式誘導体、それらの製造法およびそれらを含有する医薬組成物
JPS6216949B2 (fr)
DE2344799A1 (de) Schwefelhaltige tricyclische verbindungen und diese enthaltende arzneimittel
JPS6231704B2 (fr)
US3792063A (en) Bis chromone-2-carboxylic acids
JPS6231706B2 (fr)
US3816467A (en) 4-oxo-4h-pyrano(3,2-b)benzofuran-2-carboxylic acids and salts thereof
EP0144594B1 (fr) Dérivés de la 5H-[1]Benzopyranno[2,3,-d]pyrimidine, procédé pour leur préparation ainsi que médicaments les contenant pour la lutte contre les lésions muqueuses stomacales et duodénales
GB2035312A (en) Oxygen containing heterocylics
CH675583A5 (fr)
FI84482B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla bensodipyran.
JPS58188876A (ja) 抗炎症剤及び抗喘息剤
US3879411A (en) Ditetrazolyl-benzodipyrans
JPH01199909A (ja) 抗アレルギー用医薬組成物
CA1112651A (fr) Sel de 2,8-dicarboxy-4,6-dioxy-10-propyl-4h,6h-benzo (1,2-b:5,4-b') dipyrane
CA1259616A (fr) 4-(1h-tetrazol-5-yl)tetrazolo-[1,5-a] thienopyridines
AT300798B (de) Verfahren zur Herstellung von pharmazeutisch verwendbaren Salze des neuen Benzodipyrons
JPS60142968A (ja) 新規ジアジン−エテニルフエニルオキサミン酸
JPH0318639B2 (fr)
JPS5850225B2 (ja) 新規なキサントン類、それらの塩及びエステル並びにこれらの化合物よりなる医薬

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7908995-9

Effective date: 19940510

Format of ref document f/p: F